Author/Authors :
CAO, Zhongru Department of Medical Oncology Harbin - Medical University Cancer - Hospital, Harbin P.R. China , LI, Yuting Ward IV, Department of Breast Surgery - Harbin Medical University Cancer - Hospital, Harbin, P.R. China , WANG, Li Department of Medical Oncology - Harbin Medical University Cancer Hospital, Harbin 150040, P.R. China , LIU, Yanhua Department of Medical Oncology Harbin - Medical University Cancer - Hospital, Harbin P.R. China , ZHANG, Lei Department of Medical Oncology - Harbin Medical University Cancer - Hospital, Harbin P.R. China , MA, Li Department of Medical Oncology - Harbin Medical University Cancer - Hospital Harbin, P.R. China , AN, Yunfei Department of Medical Oncology - Harbin Medical University Cancer - Hospital Harbin, P.R. China , WANG, Yibo Department of Medical Oncology - Harbin Medical University Cancer - Hospital Harbin, P.R. China , LI, Huiyan Department of Medical Oncology - Harbin Medical University Cancer - Hospital Harbin, P.R. China
Abstract :
Background: To investigate the effect of perceptual stress reduction control intervention on the level of symptomatic groups at different time points in breast cancer.
Methods: A total of 124 breast cancer patients were divided into intervention group and control group, 62 cases in each group. Perioperative nursing and chemotherapy nursing were given to the control group, and the intervention group was given the interventional stress reduction control intervention. The level of symptom clusters of different time points were compared between the two groups.
Results: The incidence and severity of myelosuppression in the intervention group were slightly lower than those in the control group. The adverse reactions of bone marrow suppression at T3 were much lower than those in the control group, and the differences were significant (P=0.003, P=0.043). The control group had higher incidence and more severe symptoms of nausea, vomiting and diarrhea than the intervention group (P=0.002, P=0.042). The symptoms of breast pain and swelling at T1 in the intervention group were significantly lower than those in the control group (P=0.000, P=0.000). There was no significant difference in breast symptoms between the two groups at T2 and T3 (p>0.05). At the time of T2 and T3 of chemotherapy, the health promotion behavior scores of the intervention group were higher than the control group, and the difference was statistically significant (PT2=0.000, PT3=0.000).
Conclusion: Perceptual stress reduction control intervention can effectively relieve bone marrow suppression, digestive tract discomfort and breast symptoms, and promote health promotion behavior.
